US Exempts India and 19 Nations from Tariffs on Specialty Pharmaceuticals

The United States has waived tariffs on specialty drugs imported from India and 19 other countries. The exemptions stem from President Trump's April proclamation that directed adjustments to pharmaceutical and pharmaceutical ingredient imports. The move is being implemented under Section 232 of the Trade Expansion Act, a national security trade provision. The waiver is expected to ease trade conditions for major drug-exporting nations, including India, which is a significant supplier of medicines to the US market.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in